Abstract
Objectives
The aim of this work was to determine gonadotropin (LH, FSH) levels in serum and cyst fluid in various type of ovarian epithelial neoplasms (benign, borderline, malignant) and to compare them with levels in benign cysts. Additionally we decided to estimate if there were some significant correlations between serum and ovarian cyst fluid in gonadotropin levels in all investigated groups.
Materials and methods
The study group included 74 patients before (n=36) and after (n=38) menopause, divided into four groups depending on the histopathologic diagnosis. Serum and cyst fluid levels of LH and FSH were determined in all patients.
Results
We found statistically significant differences concerning LH and FSH levels in serum and cyst fluid between malignant and borderline tumors, between malignant tumors and benign cystadenomas and between malignant tumors and non-neoplastic cysts. We also found statistically significant correlations between serum and cyst fluid as to FSH and LH levels in patients with borderline tumors. There were no statistically significant correlations between serum and cyst fluid as to FSH and LH levels in patients with malignant epithelial tumors (group 1) and in patients with benign cystadenomas (group 3).
Conclusions
High FSH and LH levels in cyst fluid of malignant epithelial tumors of the ovary are in line with the gonadotropin theory of tumor growth. Simultaneous determination of various types inhibin levels appears to be an interesting topic for our future research.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blaakaer J, Micic S, Morris ID, Hording U, Bennett P, Toftager-Jansen K et al (1993) Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumors. Eur J Obstet Gynecol Reprod Biol 52:105–110
Blaakaer J, Baeksted M, Micic S, Albrectsen P Rygaard J, Bock J (1995) Gonadotropin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype. Biol Reprod 53:775–779
Chudecka-Głaz A, Rzepka-Górska I, Kosmowska B, Głaz C (1999) The levels of selected hormones in serum and in ovarian cyst fluid at girls and young women. Ginekol Pol 70:236–241
Cramer DW, Barbieri RL, Muto MD, Kelly A, Brucks JP, Harlow BL (1994) Characteristics of women with a family history of ovarian cancer. Cancer 74:1318–1322
Emons G, Weis S, Grundker C, Schultz KD (2000) LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer. Eur J Endocrinol 142:665–670
Irmer G, Burger C, Muller R, Ortmann O, Peter U, Kakar SS et al (1995) Expression of the messenger RNAs for luteinizing releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Res 55:817–822
Ivarsson K, Sundfeldt K, Brannstrom M, Hellberg P, Janson PO (2001) Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells. Hum Reprod 16:18–23
Kramer S, Leeker M, Jager W (1998) Gonadotropin levels in ovarian cyst fluids: a predictor of malignancy? Int J Biol Markers 13:165–168
Kurbacher CHM, Jager W, Kurbacher JA, Bittl A, Wildt L, Lang N (1995) Influence of human luteinizing hormone cell growth and CA 125 secretion of primary epithelial ovarian carcinoma in vitro. Tumor Biol 16:374–384
Kuroda H, Mandai M, Konishi I, Yasuichiro Y, Tsuruta Y, Hamid A et al (1998) Human chorionic gonadotropin (hCG) inhibits cisplatin-inducted apoptosis in ovarian cancer cells: possible role of up-regulation of insuline-like growth factor-1 by hCG. Int J Cancer 76:571–578
Lagiou P, Ye W, Wedren S, Ekbom A, Nyren O, Trichopoulos D, Adami HO (2001) Incidence of ovarian cancer among alcoholic women: cohort study in Sweden. Int J Cancer 91:264–266
Mandai M, Konishi I, Kuroda H, Fukumoto M, Komatsu T, Yamamoto S et al (1997) Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer 33:1501–1507
Ohtani K, Sakamoto H, Kikuchi A, Nakayama Y, Idei T, Igarshi N, Matukawa T, Satoh K (2001) Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system. Cancer Lett 166:207–213
Reimer T, Gerber B, Kunkel S, Luettich K (1997) Estradiol, gonadotropins and tumor markers in ovarian cyst fluid. Acta Obstet Gynecol Scand 76:478–483
Rzepka-Górska I, Kośmider M, Bulsa M, Kosmowska B, Malecha J (1994) LHRH analogues in epithelial ovarian cancer treatment. Ginekol Pol Suppl 3:1659–1661
Schiffenbauer YS, Abramowitch R, Meier G, Nevo N, Holzinger M, Itin A et al (1997) Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 94:13203–13208
Wimalsena J, Dostal R, Meehan D (1992) Gonadotropins, estradiol and growth factors regulate epithelial ovarian cancer cell growth. Gynecol Oncol 46:345–350
Acknowledgement
This study was supported by a grant no. 4P05A01419 from the State Committee for Scientific Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chudecka-Głaz, A., Rzepka-Górska, I. & Kosmowska, B. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary. Arch Gynecol Obstet 270, 151–156 (2004). https://doi.org/10.1007/s00404-003-0519-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-003-0519-4